CBC Radio: Injectable Peptides Called 'A Giant Scam' by Scientists
CBC investigation compares the peptide trend to historical pseudoscience, with scientists emphasizing no large-scale human trials exist for peptides sold by influencers.
#peptides
16 stories
Guardian Explainer: What Are Peptides and Is There Evidence Behind the Hype?
Comprehensive look at peptide therapies from approved GLP-1s to unregulated substances like BPC-157 and TB-500. Most evidence comes from animal studies, with benefits "largely unvalidated in human trials."
Hims & Hers Stock Retreats as Peptide Market Optimism Fades on Regulatory Uncertainty
Hims & Hers stock briefly rallied on reports the FDA may ease peptide restrictions, but gains reversed. The company had proactively acquired a peptide production facility in California in 2025.
Endpoints News: The Peptide Fad Lures Noom, Hims & Hers and Health Tech Companies
Digital health companies are betting on peptides as the next big wellness category. They're banking on HHS Secretary RFK Jr. getting the FDA to lift restrictions on certain peptides.
HIMS Stock Gains as FDA Signals Lifting Peptide Compounding Restrictions
Hims & Hers Health stock rose on reports the FDA is preparing to allow compounding pharmacies to produce previously banned injectable peptides, potentially expanding the telehealth company's operations.
FDA Poised to Reverse 2023 Peptide Ban Following RFK Jr. Advocacy
Federal regulators are moving toward restoring legal access to injectable peptides barred from pharmacy compounding in 2023, which could redirect patients from unregulated online sellers to regulated pharmacy channels.
STAT News: FDA Peptide Compounding Shift and Iran Conflict Impact on Clinical Trials
STAT's pharmaceutical roundup covers the FDA's expected move to allow compounding of previously banned peptides and the impact of the Iran conflict on global clinical trial recruitment.
FDA Expected to Lift Peptide Compounding Ban at RFK Jr.'s Urging
The FDA is moving to allow compounding pharmacies to produce 14+ injectable peptides banned in 2023. Health Secretary RFK Jr. publicly backed the reversal, while top FDA leaders reportedly have reservations about politically-driven decisions.
Wellness World Eagerly Awaits FDA Peptide Reclassification
Longevity enthusiasts anticipate FDA loosening restrictions on BPC-157, ipamorelin, and MOTs-C. Industry notes it may take months for compounding pharmacies to ramp up supply after reclassification.
Experts Warn About Safety Risks of Unproven Peptides as FDA Reversal Looms
Eric Topol of Scripps Research called peptide data "woefully minuscule," warning about impurities, random dosing, and dangerous stacking of unproven compounds from gray-market sources.
AP Investigation: Unapproved Peptide Injections Promoted by Influencers
In-depth AP investigation on influencers and celebrities promoting unapproved injectable peptides produced by compounding pharmacies without FDA-level scrutiny.
FDA Holds Historic Meeting on Allowing Peptides as Dietary Supplement Ingredients
The FDA held a public meeting to discuss broadening supplement ingredient criteria to include peptides, probiotics, and other substances. This is the first such meeting since RFK Jr. became HHS Secretary.
CNN: The 'Wild, Wild West' of Viral Peptide Claims
Report examining viral social media claims about peptides promising DNA repair, nerve relief, and wound healing, referencing RFK Jr.'s Joe Rogan appearance supporting peptide access.
Sherwood News: Peptide Gold Rush as Deregulation Triggers Industry Scramble
Companies are rushing to upgrade from gray-market research-grade to medical-grade peptide standards to supply doctors' offices as deregulation approaches.
CBS News: US Peptide Searches Hit 10.1 Million in January 2026
CBS warns that viral peptide claims on social media far outpace clinical evidence, with 60% of 10.1M monthly searches related to GLP-1 drugs and many trending peptides lacking FDA approval.
WBUR/NPR: People Buying Unregulated Injectable Peptides From Chinese Factories
Investigative journalist documents how consumers buy injectable peptides from Chinese factories via social media and Reddit. The global peptide market has swelled to $50 billion annually.